Arcturus Therapeutics Holdings IncNASDAQ:ARCT
- LAST PRICE27.4500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots26.4000/ 1
- Ask / Lots32.0000/ 2
- Open / Previous Close0.0000 / 27.4500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ARCT |
|---|---|---|
| 09:32 ET | 49355 | 27.035 |
| 09:34 ET | 1443 | 26.85 |
| 09:36 ET | 4797 | 26.86 |
| 09:38 ET | 5642 | 26.87 |
| 09:39 ET | 2230 | 27.04 |
| 09:41 ET | 2836 | 26.8475 |
| 09:43 ET | 449 | 26.8 |
| 09:45 ET | 1614 | 26.43 |
| 09:48 ET | 847 | 26.75 |
| 09:50 ET | 2191 | 26.69 |
| 09:52 ET | 1620 | 26.42 |
| 09:54 ET | 1816 | 26.34 |
| 09:56 ET | 200 | 26.26 |
| 09:57 ET | 900 | 26.24 |
| 09:59 ET | 700 | 26.24 |
| 10:01 ET | 700 | 26.43 |
| 10:03 ET | 900 | 26.57 |
| 10:06 ET | 658 | 26.69 |
| 10:08 ET | 700 | 26.835 |
| 10:10 ET | 614 | 26.83 |
| 10:12 ET | 600 | 26.9 |
| 10:14 ET | 1966 | 26.625 |
| 10:15 ET | 1000 | 26.74 |
| 10:19 ET | 200 | 26.78 |
| 10:21 ET | 3186 | 26.73 |
| 10:24 ET | 570 | 26.7823 |
| 10:26 ET | 200 | 26.76 |
| 10:28 ET | 800 | 26.785 |
| 10:30 ET | 1112 | 26.86 |
| 10:32 ET | 1009 | 26.79 |
| 10:33 ET | 249 | 26.8 |
| 10:35 ET | 500 | 26.85 |
| 10:37 ET | 100 | 26.835 |
| 10:39 ET | 700 | 26.77 |
| 10:42 ET | 1357 | 26.58 |
| 10:44 ET | 125 | 26.68 |
| 10:46 ET | 656 | 26.79 |
| 10:48 ET | 159 | 26.79 |
| 10:50 ET | 1100 | 26.875 |
| 10:51 ET | 1454 | 26.85 |
| 10:53 ET | 100 | 26.79 |
| 10:55 ET | 600 | 26.735 |
| 10:57 ET | 500 | 26.68 |
| 11:00 ET | 300 | 26.69 |
| 11:02 ET | 100 | 26.7 |
| 11:04 ET | 400 | 26.64 |
| 11:06 ET | 585 | 26.63 |
| 11:08 ET | 100 | 26.57 |
| 11:09 ET | 2600 | 26.53 |
| 11:11 ET | 544 | 26.54 |
| 11:13 ET | 300 | 26.58 |
| 11:15 ET | 100 | 26.6 |
| 11:18 ET | 2648 | 26.645 |
| 11:20 ET | 1136 | 26.575 |
| 11:24 ET | 400 | 26.58 |
| 11:26 ET | 400 | 26.595 |
| 11:27 ET | 3839 | 26.53 |
| 11:29 ET | 2000 | 26.625 |
| 11:31 ET | 2800 | 26.65 |
| 11:33 ET | 898 | 26.79 |
| 11:36 ET | 910 | 26.91 |
| 11:38 ET | 400 | 27.03 |
| 11:40 ET | 1608 | 26.92 |
| 11:42 ET | 700 | 26.79 |
| 11:44 ET | 100 | 26.77 |
| 11:45 ET | 1500 | 26.64 |
| 11:47 ET | 1073 | 26.665 |
| 11:49 ET | 1200 | 26.67 |
| 11:51 ET | 200 | 26.68 |
| 11:54 ET | 722 | 26.66 |
| 11:56 ET | 499 | 26.655 |
| 11:58 ET | 200 | 26.645 |
| 12:00 ET | 1828 | 26.64 |
| 12:02 ET | 900 | 26.705 |
| 12:05 ET | 300 | 26.68 |
| 12:07 ET | 600 | 26.76 |
| 12:09 ET | 810 | 26.71 |
| 12:12 ET | 200 | 26.72 |
| 12:14 ET | 100 | 26.76 |
| 12:16 ET | 1968 | 26.57 |
| 12:18 ET | 300 | 26.54 |
| 12:20 ET | 2239 | 26.76 |
| 12:21 ET | 600 | 26.73 |
| 12:23 ET | 100 | 26.73 |
| 12:25 ET | 200 | 26.75 |
| 12:27 ET | 865 | 26.67 |
| 12:30 ET | 778 | 26.75 |
| 12:32 ET | 912 | 26.78 |
| 12:34 ET | 100 | 26.82 |
| 12:36 ET | 400 | 26.75 |
| 12:38 ET | 400 | 26.77 |
| 12:39 ET | 800 | 26.8 |
| 12:43 ET | 500 | 26.87 |
| 12:45 ET | 904 | 26.885 |
| 12:48 ET | 200 | 26.91 |
| 12:50 ET | 2839 | 26.82 |
| 12:52 ET | 200 | 26.83 |
| 12:54 ET | 500 | 26.89 |
| 12:56 ET | 800 | 26.88 |
| 12:57 ET | 1821 | 26.97 |
| 12:59 ET | 200 | 26.98 |
| 01:01 ET | 400 | 27.02 |
| 01:03 ET | 200 | 26.99 |
| 01:06 ET | 300 | 27.105 |
| 01:08 ET | 400 | 27.1595 |
| 01:10 ET | 100 | 27.06 |
| 01:12 ET | 800 | 27.06 |
| 01:15 ET | 100 | 27.08 |
| 01:17 ET | 500 | 27.05 |
| 01:19 ET | 500 | 27 |
| 01:24 ET | 1700 | 26.975 |
| 01:26 ET | 200 | 27.035 |
| 01:28 ET | 700 | 27.11 |
| 01:30 ET | 889 | 27.14 |
| 01:32 ET | 600 | 27.28 |
| 01:33 ET | 1066 | 27.28 |
| 01:35 ET | 1710 | 27.37 |
| 01:37 ET | 978 | 27.4099 |
| 01:39 ET | 300 | 27.39 |
| 01:42 ET | 503 | 27.41 |
| 01:44 ET | 737 | 27.3 |
| 01:46 ET | 820 | 27.39 |
| 01:48 ET | 500 | 27.39 |
| 01:50 ET | 3187 | 27.37 |
| 01:51 ET | 1739 | 27.3579 |
| 01:53 ET | 1000 | 27.42 |
| 01:55 ET | 100 | 27.405 |
| 01:57 ET | 400 | 27.47 |
| 02:00 ET | 501 | 27.35 |
| 02:02 ET | 400 | 27.21 |
| 02:06 ET | 639 | 27.29 |
| 02:08 ET | 600 | 27.32 |
| 02:09 ET | 300 | 27.33 |
| 02:11 ET | 1539 | 27.27 |
| 02:13 ET | 200 | 27.24 |
| 02:15 ET | 500 | 27.345 |
| 02:18 ET | 700 | 27.455 |
| 02:20 ET | 300 | 27.46 |
| 02:22 ET | 1162 | 27.43 |
| 02:24 ET | 1200 | 27.4 |
| 02:26 ET | 327 | 27.41 |
| 02:27 ET | 100 | 27.52 |
| 02:29 ET | 961 | 27.43 |
| 02:31 ET | 752 | 27.485 |
| 02:33 ET | 1400 | 27.45 |
| 02:36 ET | 655 | 27.48 |
| 02:38 ET | 2593 | 27.52 |
| 02:40 ET | 329 | 27.53 |
| 02:42 ET | 4868 | 27.382 |
| 02:44 ET | 649 | 27.39 |
| 02:45 ET | 908 | 27.365 |
| 02:47 ET | 2100 | 27.41 |
| 02:49 ET | 2727 | 27.58 |
| 02:51 ET | 2127 | 27.72 |
| 02:54 ET | 829 | 27.58 |
| 02:56 ET | 1000 | 27.56 |
| 02:58 ET | 1090 | 27.57 |
| 03:00 ET | 1444 | 27.56 |
| 03:02 ET | 1300 | 27.49 |
| 03:03 ET | 200 | 27.5 |
| 03:05 ET | 2156 | 27.42 |
| 03:07 ET | 5500 | 27.54 |
| 03:09 ET | 2535 | 27.54 |
| 03:12 ET | 1163 | 27.48 |
| 03:14 ET | 608 | 27.55 |
| 03:16 ET | 1400 | 27.58 |
| 03:18 ET | 2133 | 27.49 |
| 03:20 ET | 1824 | 27.44 |
| 03:21 ET | 1200 | 27.42 |
| 03:23 ET | 1755 | 27.469 |
| 03:25 ET | 1794 | 27.49 |
| 03:27 ET | 5274 | 27.6 |
| 03:30 ET | 4392 | 27.66 |
| 03:32 ET | 1550 | 27.53 |
| 03:34 ET | 7053 | 27.53 |
| 03:36 ET | 2809 | 27.54 |
| 03:38 ET | 8604 | 27.3 |
| 03:39 ET | 2317 | 27.2625 |
| 03:41 ET | 7946 | 27.1 |
| 03:43 ET | 3866 | 27.13 |
| 03:45 ET | 2259 | 27.125 |
| 03:48 ET | 8578 | 27.13 |
| 03:50 ET | 6776 | 27.07 |
| 03:52 ET | 8469 | 27.09 |
| 03:54 ET | 5479 | 27.19 |
| 03:56 ET | 13876 | 27.44 |
| 03:57 ET | 14258 | 27.38 |
| 03:59 ET | 17351 | 27.45 |
Jun 20, 2024
Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors, from 8:00AM ET on Thursday Jun 20, 2024 by Dow Jones
8:00AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 7, 2024
DJ Arcturus Therapeutics Down Over 22%, on Pace for Largest Percent Decrease Since August 2021 -- Data Talk, from 1:30PM ET on Friday Jun 07, 2024 by Dow Jones
1:30PM ET on Friday Jun 07, 2024 by Dow JonesArcturus Therapeutics Presents New Clinical Data at 47(th) Annual European Cystic Fibrosis Conference, from 10:30AM ET on Friday Jun 07, 2024 by Dow Jones
10:30AM ET on Friday Jun 07, 2024 by Dow Jones
May 28, 2024
DJ Arcturus Therapeutics Shares Jump 23% on Positive Observations for Potential Cystic Fibrosis Treatment, from 11:55AM ET on Tuesday May 28, 2024 by Dow Jones
11:55AM ET on Tuesday May 28, 2024 by Dow JonesArcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program, from 6:30AM ET on Tuesday May 28, 2024 by Dow Jones
6:30AM ET on Tuesday May 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcturus Therapeutics Holdings Inc | 739.3M | -6.8x | --- |
Aurinia Pharmaceuticals Inc | 790.9M | -12.7x | --- |
Adaptive Biotechnologies Corp | 477.5M | -2.2x | --- |
Travere Therapeutics Inc | 556.5M | -1.4x | --- |
Anika Therapeutics Inc | 385.5M | -5.0x | --- |
Avid Bioservices Inc | 478.6M | -26.1x | --- |
Company Information
Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose level. It is leveraging its LUNAR platform and its nucleic acid technologies to develop and advance a pipeline of mRNA-based vaccines and therapeutics for infectious diseases and rare genetic disorders with significant unmet medical needs. Its COVID-19 vaccine candidate, which is based on its STARR technology platform is through Phase II clinical trials.
Contact Information
- Headquarters
- 10628 Science Center Dr Ste 250SAN DIEGO, CA, United States 92121-1132
- Phone
- 858-900-2660
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Peter Farrell
- President, Chief Executive Officer, Director
- Joseph Payne
- Chief Financial Officer, Director
- Andrew Sassine
- Chief Operating Officer, Chief Scientific Officer
- Padmanabh Chivukula
- Chief Legal Officer
- Lance Kurata
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $739.3M |
|---|---|
Revenue (TTM) | $124.5M |
Shares Outstanding | 26.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.65 |
EPS | $-4.02 |
Book Value | $10.38 |
P/E Ratio | -6.8x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
